SPECIAL FEATURES:
-Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like afatinib, ceritinib, ibrutinib, idelalisib, obinutuzumab, and ramucirumab.
-A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens.
-Diagrams of drug structures and pathways for many of the agents.
-Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages.
-Covers toxicity and drug-drug interactions.
-A section on chemotherapy regimens for all major cancers.
-Provides an overview of the basic principles of cancer drug therapy.